Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220019921 220009401 1.72 78.1 null 2016-11-11 2016-12-09 ALL UKALL2011 TRIAL 02 N 220035535 GEMCITABINE
220019925 220014991 1.69 60 Curative (C) 2015-01-08 2015-01-09 Cytarabine + Idarubicin N null 220035549 MA
220019926 220009413 null null Palliative (P) 2017-09-19 2017-09-19 GDP N null 220035566 METHOTREXATE HIGH DOSE
220019927 220009420 1.73 86.5 Curative (C) 2015-02-22 2015-02-25 CAMELLIA Trial N N 220035603 AFATINIB
220019928 220009423 1.74 63.6 Curative (C) 2014-08-22 2014-08-29 DABRAFENIB N N 220035632 DOXORUBICIN
220019929 220009427 1.6 62.3 Curative (C) 2016-07-08 2016-07-16 Carboplatin AUC 6 - 10 N N 220035638 FCR
220019930 220009432 1.67 55.8 null 2014-07-28 2015-08-06 MA (Cytarabine 3g/m2) N N 220035672 PEMBROLIZUMAB
220019931 220009438 1.67 51.3 Curative (C) 2018-04-13 2018-04-24 PEMBROLIZUMAB 02 N 220035738 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220019932 220009439 null 95 Curative (C) 2017-05-09 2017-10-04 MidAC null N 220035742 LIPOSOMAL CYTARABINE
220019934 220015008 1.6 null Curative (C) 2017-09-11 2018-04-14 Arsenic Triox + Tretinoin Ind W1-4 3 N 220035765 WT1 TRIAL
220019936 220009451 1.56 120 Curative (C) 2016-11-13 2016-11-20 Fluorouracil + Folinic Acid Weekly 2 N 220035793 MITOXANTRONE + TRETINOIN
220019937 220015014 1.3 null Curative (C) 2015-01-19 2015-01-19 FLUDARABINE N N 220035797 IMATINIB + HYDROXYCARBAMIDE
220019938 220015019 1.71 80.4 Curative (C) 2015-05-28 2015-06-01 DABRAFENIB + TRAMETINIB N N 220035882 FLUOROURACIL + IRINOTECAN + OXALIPLATIN
220019939 220009471 1.69 62.2 Curative (C) 2014-10-30 2014-12-20 Liposomal Doxorubicin (Caelyx) Y N 220035925 UKALL 2011
220019940 220018197 null null Curative (C) 2013-12-14 2013-12-14 MELPHALAN null null 220035943 ALEMTUZUMAB + FLUDARABINE
220019941 220009475 1.69 80 Curative (C) 2017-04-22 2017-05-10 PEMBROLIZUMAB 01 N 220035947 CETUXIMAB
220019942 220009481 1.83 108.5 Curative (C) 2017-05-11 2017-05-18 Fludarabine IV 1 N 220035962 BUSULFAN + CYCLOPHOSPHAMIDE
220019943 220015033 1.75 102.7 Palliative (P) 2015-12-26 2016-01-07 CETUXIMAB + RT N N 220036003 IPILIMUMAB
220019944 220009489 1.8 111 Curative (C) 2014-02-25 2014-05-20 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE 02 N 220036013 CYTARABINE + MITOXANTRONE
220019945 220009492 0 72.1 Not known (9) 2014-12-21 2015-03-12 ATG + BUSULFAN + CYCLOPHOSPHAMIDE N N 220036034 ROMAZA TRIAL
220019946 220015037 null 88.3 null 2014-05-26 2014-06-09 DA-EPOCH-R 02 N 220036041 LENALIDOMIDE
220019947 220009495 1.83 69 Curative (C) 2015-08-25 2016-10-30 CISPLATIN + ETOPOSIDE N N 220036053 BUSULFAN + CYCLOPHOSPHAMIDE + FLUDARABINE
220019948 220009497 1.64 80 Disease modification (D) 2016-12-11 2016-12-16 FEC 100 N N 220036057 TRASTUZUMAB
220019949 220009500 1.76 83 Palliative (P) 2015-03-26 2015-08-24 DABRAFENIB 2 N 220036062 PEMETREXED
220019950 220009510 null null Curative (C) 2015-10-14 2015-10-14 BUSULFAN + CYCLO N Y 220036121 FLUDARABINE
220019952 220009526 1.65 null Curative (C) 2015-10-13 2015-11-20 Spanish Maintenance (Months 4-24) null null 220036202 PERTUZUMAB
220019953 220009530 1.67 54.2 Curative (C) 2014-09-20 2014-09-21 MidAC N N 220036215 ARSENIC TRIOXIDE + ATRA
220019954 220009533 1.71 71.8 Curative (C) 2016-07-06 2016-07-12 INTERFERON 02 N 220036225 CAPECITABINE + OXALIPLATIN
220019955 220019992 1.78 null null 2017-12-02 2017-12-02 MELPHALAN N N 220036228 EOX
220019957 220009539 1.83 83.2 Curative (C) 2017-03-17 2017-06-16 Cetuximab 14 day N N 220036240 UKALL 2011
220019958 220019993 1.7 84.8 Curative (C) 2018-11-30 2019-01-03 Arsenic trioxide N N 220036248 CAMELLIA TRIAL
220019959 220021928 1.75 null Disease modification (D) 2017-09-15 2017-09-26 FIGARO TRIAL N N 220036280 CYTARABINE + ETOPOSIDE
220019960 220009547 null null Curative (C) null 2015-07-11 Cytarabine+Methotrexate Intrathecal N null 220036297 CYTARABINE IT + METHOTREXATE
220019961 220009550 1.65 65.7 Disease modification (D) 2016-12-01 2017-05-17 BUSULFAN + FLUDARABINE + METHOTREXATE 02 N 220036312 IPO
220019962 220009558 1.78 94.2 null 2016-12-15 2017-05-21 Arsenic Triox + Tretinoin Ind W1-4 01 N 220036334 LENALIDOMIDE
220019963 220009559 null 74 Palliative (P) 2016-09-12 2016-10-20 ALEMTUZUMAB + FLUDARABINE 02 N 220036338 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN
220019964 220009566 null null Curative (C) 2014-05-18 2014-05-18 DA-EPOCH-R N N 220036395 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220019965 220009571 1.57 0 Disease modification (D) 2017-05-09 2017-06-19 CYTARABINE + FLUDARABINE 2 N 220036412 IRINOTECAN
220019966 220009572 1.71 105 Palliative (P) 2017-02-25 2017-03-01 DABRAFENIB N N 220036413 PEMBROLIZUMAB
220019967 220009577 null null Curative (C) 2018-03-05 2018-03-05 LENALIDOMIDE null null 220036432 ETOPOSIDE + IDARUBICIN
220019968 220009587 1.81 97 Curative (C) 2017-07-16 2017-09-20 CYTARABINE + MITOXANTRONE 01 N 220036453 FIGARO TRIAL
220019969 220018225 1.8 79.9 Palliative (P) 2016-12-21 2017-03-14 MERCAPTOPURINE + METHOTREXATE N N 220036524 UKALL 2011
220019971 220009607 1.62 96.8 Curative (C) 2018-05-15 2018-05-20 INTERFERON 02 N 220036563 INTERFERON
220019972 220009610 1.84 41.2 Disease modification (D) 2014-06-19 2014-07-02 MidAC N N 220036575 IBRUTINIB
220019973 220009619 null 86 Palliative (P) 2014-07-10 2014-07-16 TIP 99 null 220036606 CYTARABINE IT + METHOTREXATE
220019974 220009625 1.86 null Curative (C) 2015-03-07 2015-12-31 MACE N N 220036614 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220019975 220018230 null 64.7 Disease modification (D) 2012-12-29 2012-12-29 VIDE N N 220036619 VINORELBINE
220019976 220009630 1.68 73.8 Curative (C) 2017-10-03 2017-10-03 IPM 02 N 220036629 BUSULPHAN + CYCLO
220019977 220009636 1.65 125 Disease modification (D) 2017-05-22 2017-05-26 Busulfan + Cyclophos Conditioning N N 220036633 MITOXANTRONE + TRETINOIN
220019978 220009640 1.72 72.5 Disease modification (D) 2014-11-04 2014-11-11 EOX 02 N 220036641 CETUXIMAB + IRINOTECAN + MDG